1. Home
  2. CELU vs AAME Comparison

CELU vs AAME Comparison

Compare CELU & AAME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • AAME
  • Stock Information
  • Founded
  • CELU 2016
  • AAME 1968
  • Country
  • CELU United States
  • AAME United States
  • Employees
  • CELU N/A
  • AAME N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • AAME Life Insurance
  • Sector
  • CELU Health Care
  • AAME Finance
  • Exchange
  • CELU Nasdaq
  • AAME Nasdaq
  • Market Cap
  • CELU 64.3M
  • AAME 68.4M
  • IPO Year
  • CELU N/A
  • AAME N/A
  • Fundamental
  • Price
  • CELU $2.15
  • AAME $3.44
  • Analyst Decision
  • CELU Strong Buy
  • AAME
  • Analyst Count
  • CELU 1
  • AAME 0
  • Target Price
  • CELU $6.00
  • AAME N/A
  • AVG Volume (30 Days)
  • CELU 136.2K
  • AAME 38.7K
  • Earning Date
  • CELU 08-29-2025
  • AAME 11-11-2025
  • Dividend Yield
  • CELU N/A
  • AAME 0.59%
  • EPS Growth
  • CELU N/A
  • AAME N/A
  • EPS
  • CELU N/A
  • AAME 0.10
  • Revenue
  • CELU $44,590,000.00
  • AAME $198,977,000.00
  • Revenue This Year
  • CELU N/A
  • AAME N/A
  • Revenue Next Year
  • CELU $76.00
  • AAME N/A
  • P/E Ratio
  • CELU N/A
  • AAME $32.42
  • Revenue Growth
  • CELU 4.45
  • AAME 6.98
  • 52 Week Low
  • CELU $1.00
  • AAME $1.25
  • 52 Week High
  • CELU $5.22
  • AAME $3.71
  • Technical
  • Relative Strength Index (RSI)
  • CELU 34.61
  • AAME 66.93
  • Support Level
  • CELU $2.05
  • AAME $3.20
  • Resistance Level
  • CELU $2.41
  • AAME $3.35
  • Average True Range (ATR)
  • CELU 0.30
  • AAME 0.20
  • MACD
  • CELU -0.10
  • AAME -0.03
  • Stochastic Oscillator
  • CELU 6.57
  • AAME 86.67

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About AAME Atlantic American Corporation

Atlantic American Corp operates in specialty markets within the life and health and property and casualty insurance industries. The company has two segments: American Southern, It provides property and casualty insurance including bodily injury and property damage liability coverage, uninsured motorist coverage, and physical damage coverage for commercial accounts, and Bankers Fidelity, the company's life and health operations offer a variety of life and supplemental health products including ordinary and term life insurance, Medicare supplement, and other health insurance.

Share on Social Networks: